Cox Aaron is a director or executive at Lakefront Biotherapeutics, a position that grants privileged access to material non-public information. As such, they are subject to EU Market Abuse Regulation disclosure requirements and must report regulated securities transactions to maintain market transparency and regulatory compliance.
Rendement 1 an
-0.2%
Historique des transactions
1
Historique des transactions
1 transaction signal· 2 déclarées brutes1 transaction exclue des classements de signal. Un ou plusieurs dépôts pour cette personne semblent concerner une consolidation de compte, des transferts ou une restructuration de portefeuille. Affichés ci-dessous pour transparence mais exclus des calculs de performance et des flux de signaux.
Côté
🇧🇪
Neutral — compensation/vestingCox AaronEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
Undisclosed
Not an insider buy/sell signal. This transaction is part of a compensation or vesting arrangement. Shares received through remuneration and subsequently sold for tax or liquidity purposes are classified as neutral and excluded from signal analysis.